AMPEL BioSolutions' predicts drug options with RNA analytics & machine learning

Vaccizone selects Exothera for GMP manufacturing of its SARS?CoV?2 vaccine

Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells

Vividion Therapeutics names Aleksandra Rizo as President and Head of R&D

Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.

Nuvectis announces positive data for NXP900 in a preclinical model of Group 4 medulloblastoma

Group 4 Medulloblastoma is a rare disease that mostly affects pediatric patients, in which aberrant SRC signaling was identified as a hallmark of the disease

Karkinos Healthcare launched ‘Advanced Center for Cancer Diagnostics and Research’

India’s first oncology laboratory for comprehensive Cancer Diagnostic services

National Ayurveda Research Institute for Panchakarma bags NABL Accreditation

A big boost to healthcare efforts of Ayush through NARIP, CCRAS

Launch of joint research to collect a year’s worth of lifestyle data through wearable tracking device

Objective tracking data combined with cohort data to drive medicine of the future

Micro-Tech Endoscopy partners with Wision A.I. to distribute polyp detection software in the U.S.

The technology was able to identify approximately 32 percent more adenomas than standard colonoscopy procedures

SIMS Hospital conducts high-performance hip replacement surgery

The patient, who was previously diagnosed with osteoarthritis, was prescribed hip replacement surgery as the best and most effective solution for his condition

AbbVie and Cugene announce collaboration in autoimmune diseases

AbbVie receives the option to license worldwide rights to CUG252 from Cugene, a clinical-stage and potential best-in-class Treg-selective IL-2 mutein, building on AbbVie's commitment to developing novel therapies in immunology